Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors.

Trial Profile

Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 15 Sep 2011

At a glance

  • Drugs Doxorubicin liposomal; Everolimus
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Sep 2011 Planned End Date changed from 1 Feb 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
    • 30 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top